市場調査レポート
商品コード
1341056

DNAシーケンサーの世界市場 2023-2027

Global DNA Sequencing Market 2023-2027

出版日: | 発行: TechNavio | ページ情報: 英文 168 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
DNAシーケンサーの世界市場 2023-2027
出版日: 2023年08月07日
発行: TechNavio
ページ情報: 英文 168 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

DNAシーケンサーの世界市場2022-2026

Technavio社は、DNAシーケンサー市場をモニターしており、2022年から2026年にかけて235億6,000万米ドル、予測期間中のCAGRは20.85%で成長する見通しです。当レポートでは、DNAシーケンサー市場の全体的な分析、市場規模・予測、動向、市場促進要因・促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の世界の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、NGSの採用拡大、DNAシーケンサーの低価格化、DNAシーケンサーの用途拡大によって牽引されています。

本調査では、今後数年間におけるDNAシーケンサー市場の成長を促進する主な理由の一つとして、第三世代シーケンス法の出現を挙げています。また、NGS用の高度なバイオインフォマティクスツールの開発とDNAシーケンサーの自動化は、市場の大きな需要につながるでしょう。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2022
  • 市場の見通し 2022-2027

第4章 市場規模実績

  • DNAシーケンサーの世界市場 2017-2021
  • エンドユーザー別セグメント分析 2017-2021
  • ソリューション別セグメント分析 2017-2021
  • 地域別セグメント分析 2017-2021
  • 国別セグメント分析 2017-2021

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:エンドユーザー別

  • 市場セグメント
  • 比較:エンドユーザー別
  • 学術調査:市場規模と予測 2022-2027
  • 臨床調査:市場規模と予測 2022-2027
  • 病院と診療所:市場規模と予測 2022-2027
  • 製薬会社およびバイオテクノロジー会社:市場規模と予測 2022-2027
  • 市場機会:エンドユーザー別

第7章 市場セグメンテーション:ソリューション別

  • 市場セグメント
  • 比較:ソリューション別
  • 製品:市場規模と予測 2022-2027
  • サービス:市場規模と予測 2022-2027
  • 市場機会:ソリューション別

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2022-2027
  • 欧州:市場規模と予測 2022-2027
  • アジア:市場規模と予測 2022-2027
  • 世界のその他の地域:市場規模と予測 2022-2027
  • 米国:市場規模と予測 2022-2027
  • 英国:市場規模と予測 2022-2027
  • ドイツ:市場規模と予測 2022-2027
  • 中国:市場規模と予測 2022-2027
  • 日本:市場規模と予測 2022-2027
  • 市場機会:地域情勢別

第10章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第11章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • 10X Genomics Inc.
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Azenta Inc.
  • Becton Dickinson and Co.
  • BGI Genomics Co. Ltd.
  • Bio Rad Laboratories Inc.
  • Danaher Corp.
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd.
  • Illumina Inc.
  • Macrogen Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Solution
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on global dna sequencing market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Solution Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by End-user
  • Exhibits33: Data Table on Comparison by End-user
  • Exhibits34: Chart on Academic research - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Academic research - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Academic research - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Academic research - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
  • Exhibits43: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
  • Exhibits44: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
  • Exhibits45: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
  • Exhibits46: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
  • Exhibits47: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
  • Exhibits48: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
  • Exhibits49: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
  • Exhibits50: Market opportunity by End-user ($ million)
  • Exhibits51: Data Table on Market opportunity by End-user ($ million)
  • Exhibits52: Chart on Solution - Market share 2022-2027 (%)
  • Exhibits53: Data Table on Solution - Market share 2022-2027 (%)
  • Exhibits54: Chart on Comparison by Solution
  • Exhibits55: Data Table on Comparison by Solution
  • Exhibits56: Chart on Products - Market size and forecast 2022-2027 ($ million)
  • Exhibits57: Data Table on Products - Market size and forecast 2022-2027 ($ million)
  • Exhibits58: Chart on Products - Year-over-year growth 2022-2027 (%)
  • Exhibits59: Data Table on Products - Year-over-year growth 2022-2027 (%)
  • Exhibits60: Chart on Services - Market size and forecast 2022-2027 ($ million)
  • Exhibits61: Data Table on Services - Market size and forecast 2022-2027 ($ million)
  • Exhibits62: Chart on Services - Year-over-year growth 2022-2027 (%)
  • Exhibits63: Data Table on Services - Year-over-year growth 2022-2027 (%)
  • Exhibits64: Market opportunity by Solution ($ million)
  • Exhibits65: Data Table on Market opportunity by Solution ($ million)
  • Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits69: Chart on Geographic comparison
  • Exhibits70: Data Table on Geographic comparison
  • Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits105: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits107: Market opportunity By Geographical Landscape ($ million)
  • Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits109: Impact of drivers and challenges in 2022 and 2027
  • Exhibits110: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits111: Overview on factors of disruption
  • Exhibits112: Impact of key risks on business
  • Exhibits113: Vendors covered
  • Exhibits114: Matrix on vendor position and classification
  • Exhibits115: 10X Genomics Inc. - Overview
  • Exhibits116: 10X Genomics Inc. - Product / Service
  • Exhibits117: 10X Genomics Inc. - Key offerings
  • Exhibits118: Abbott Laboratories - Overview
  • Exhibits119: Abbott Laboratories - Business segments
  • Exhibits120: Abbott Laboratories - Key news
  • Exhibits121: Abbott Laboratories - Key offerings
  • Exhibits122: Abbott Laboratories - Segment focus
  • Exhibits123: Agilent Technologies Inc. - Overview
  • Exhibits124: Agilent Technologies Inc. - Business segments
  • Exhibits125: Agilent Technologies Inc. - Key offerings
  • Exhibits126: Agilent Technologies Inc. - Segment focus
  • Exhibits127: Azenta Inc. - Overview
  • Exhibits128: Azenta Inc. - Business segments
  • Exhibits129: Azenta Inc. - Key offerings
  • Exhibits130: Azenta Inc. - Segment focus
  • Exhibits131: Becton Dickinson and Co. - Overview
  • Exhibits132: Becton Dickinson and Co. - Business segments
  • Exhibits133: Becton Dickinson and Co. - Key news
  • Exhibits134: Becton Dickinson and Co. - Key offerings
  • Exhibits135: Becton Dickinson and Co. - Segment focus
  • Exhibits136: BGI Genomics Co. Ltd. - Overview
  • Exhibits137: BGI Genomics Co. Ltd. - Product / Service
  • Exhibits138: BGI Genomics Co. Ltd. - Key offerings
  • Exhibits139: Bio Rad Laboratories Inc. - Overview
  • Exhibits140: Bio Rad Laboratories Inc. - Business segments
  • Exhibits141: Bio Rad Laboratories Inc. - Key news
  • Exhibits142: Bio Rad Laboratories Inc. - Key offerings
  • Exhibits143: Bio Rad Laboratories Inc. - Segment focus
  • Exhibits144: Danaher Corp. - Overview
  • Exhibits145: Danaher Corp. - Business segments
  • Exhibits146: Danaher Corp. - Key news
  • Exhibits147: Danaher Corp. - Key offerings
  • Exhibits148: Danaher Corp. - Segment focus
  • Exhibits149: Eurofins Scientific SE - Overview
  • Exhibits150: Eurofins Scientific SE - Business segments
  • Exhibits151: Eurofins Scientific SE - Key news
  • Exhibits152: Eurofins Scientific SE - Key offerings
  • Exhibits153: Eurofins Scientific SE - Segment focus
  • Exhibits154: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits155: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits156: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits157: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits158: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits159: Illumina Inc. - Overview
  • Exhibits160: Illumina Inc. - Business segments
  • Exhibits161: Illumina Inc. - Key news
  • Exhibits162: Illumina Inc. - Key offerings
  • Exhibits163: Illumina Inc. - Segment focus
  • Exhibits164: Macrogen Inc. - Overview
  • Exhibits165: Macrogen Inc. - Product / Service
  • Exhibits166: Macrogen Inc. - Key offerings
  • Exhibits167: PerkinElmer Inc. - Overview
  • Exhibits168: PerkinElmer Inc. - Business segments
  • Exhibits169: PerkinElmer Inc. - Key news
  • Exhibits170: PerkinElmer Inc. - Key offerings
  • Exhibits171: PerkinElmer Inc. - Segment focus
  • Exhibits172: QIAGEN NV - Overview
  • Exhibits173: QIAGEN NV - Product / Service
  • Exhibits174: QIAGEN NV - Key news
  • Exhibits175: QIAGEN NV - Key offerings
  • Exhibits176: Thermo Fisher Scientific Inc. - Overview
  • Exhibits177: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits178: Thermo Fisher Scientific Inc. - Key news
  • Exhibits179: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits180: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits181: Inclusions checklist
  • Exhibits182: Exclusions checklist
  • Exhibits183: Currency conversion rates for US$
  • Exhibits184: Research methodology
  • Exhibits185: Validation techniques employed for market sizing
  • Exhibits186: Information sources
  • Exhibits187: List of abbreviations
目次
Product Code: IRTNTR40874

Global DNA Sequencing Market 2022-2026

Technavio has been monitoring the DNA sequencing market and it is poised to grow by $ 23.56 bn during 2022-2026, accelerating at a CAGR of 20.85% during the forecast period. Our report on the DNA sequencing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing adoption of NGS, increasing affordability of DNA sequencing, and expanding applications of DNA sequencing.

The DNA sequencing market analysis includes the solution segment and geographic landscape.

Technavio's DNA sequencing market is segmented as below:

By Solution

  • Product
  • Services

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the emergence of third-generation sequencing methods as one of the prime reasons driving the DNA sequencing market growth during the next few years. Also, the development of sophisticated bioinformatics tools for NGS and automation of DNA sequencing will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on DNA sequencing market covers the following areas:

  • DNA sequencing market sizing
  • DNA sequencing market forecast
  • DNA sequencing market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading DNA sequencing market vendors that include 10X Genomics Inc., Abbott Laboratories, Agilent Technologies Inc., Azenta US Inc., Becton Dickinson and Co., BGI Group, Bio Rad Laboratories Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Macrogen Inc., Merck KGaA, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN NV, SeqLL Inc., Tecan Group Ltd., and Thermo Fisher Scientific Inc. Also, the DNA sequencing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Solution
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global DNA sequencing market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global dna sequencing market 2017 - 2021 ($ million)
  • 4.2 End-user Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
  • 4.3 Solution Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Solution Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

  • 6.1 Market segments
  • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
  • 6.2 Comparison by End-user
  • Exhibit 32: Chart on Comparison by End-user
  • Exhibit 33: Data Table on Comparison by End-user
  • 6.3 Academic research - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Academic research - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Academic research - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Academic research - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Academic research - Year-over-year growth 2022-2027 (%)
  • 6.4 Clinical research - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
  • 6.5 Hospitals and clinics - Market size and forecast 2022-2027
  • Exhibit 42: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 43: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 44: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
  • Exhibit 45: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
  • 6.6 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
  • Exhibit 46: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 47: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 48: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
  • Exhibit 49: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
  • 6.7 Market opportunity by End-user
  • Exhibit 50: Market opportunity by End-user ($ million)
  • Exhibit 51: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Solution

  • 7.1 Market segments
  • Exhibit 52: Chart on Solution - Market share 2022-2027 (%)
  • Exhibit 53: Data Table on Solution - Market share 2022-2027 (%)
  • 7.2 Comparison by Solution
  • Exhibit 54: Chart on Comparison by Solution
  • Exhibit 55: Data Table on Comparison by Solution
  • 7.3 Products - Market size and forecast 2022-2027
  • Exhibit 56: Chart on Products - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Data Table on Products - Market size and forecast 2022-2027 ($ million)
  • Exhibit 58: Chart on Products - Year-over-year growth 2022-2027 (%)
  • Exhibit 59: Data Table on Products - Year-over-year growth 2022-2027 (%)
  • 7.4 Services - Market size and forecast 2022-2027
  • Exhibit 60: Chart on Services - Market size and forecast 2022-2027 ($ million)
  • Exhibit 61: Data Table on Services - Market size and forecast 2022-2027 ($ million)
  • Exhibit 62: Chart on Services - Year-over-year growth 2022-2027 (%)
  • Exhibit 63: Data Table on Services - Year-over-year growth 2022-2027 (%)
  • 7.5 Market opportunity by Solution
  • Exhibit 64: Market opportunity by Solution ($ million)
  • Exhibit 65: Data Table on Market opportunity by Solution ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 69: Chart on Geographic comparison
  • Exhibit 70: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 UK - Market size and forecast 2022-2027
  • Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.9 Germany - Market size and forecast 2022-2027
  • Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.10 China - Market size and forecast 2022-2027
  • Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.11 Japan - Market size and forecast 2022-2027
  • Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 107: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 109: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 111: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 112: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 113: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 114: Matrix on vendor position and classification
  • 12.3 10X Genomics Inc.
  • Exhibit 115: 10X Genomics Inc. - Overview
  • Exhibit 116: 10X Genomics Inc. - Product / Service
  • Exhibit 117: 10X Genomics Inc. - Key offerings
  • 12.4 Abbott Laboratories
  • Exhibit 118: Abbott Laboratories - Overview
  • Exhibit 119: Abbott Laboratories - Business segments
  • Exhibit 120: Abbott Laboratories - Key news
  • Exhibit 121: Abbott Laboratories - Key offerings
  • Exhibit 122: Abbott Laboratories - Segment focus
  • 12.5 Agilent Technologies Inc.
  • Exhibit 123: Agilent Technologies Inc. - Overview
  • Exhibit 124: Agilent Technologies Inc. - Business segments
  • Exhibit 125: Agilent Technologies Inc. - Key offerings
  • Exhibit 126: Agilent Technologies Inc. - Segment focus
  • 12.6 Azenta Inc.
  • Exhibit 127: Azenta Inc. - Overview
  • Exhibit 128: Azenta Inc. - Business segments
  • Exhibit 129: Azenta Inc. - Key offerings
  • Exhibit 130: Azenta Inc. - Segment focus
  • 12.7 Becton Dickinson and Co.
  • Exhibit 131: Becton Dickinson and Co. - Overview
  • Exhibit 132: Becton Dickinson and Co. - Business segments
  • Exhibit 133: Becton Dickinson and Co. - Key news
  • Exhibit 134: Becton Dickinson and Co. - Key offerings
  • Exhibit 135: Becton Dickinson and Co. - Segment focus
  • 12.8 BGI Genomics Co. Ltd.
  • Exhibit 136: BGI Genomics Co. Ltd. - Overview
  • Exhibit 137: BGI Genomics Co. Ltd. - Product / Service
  • Exhibit 138: BGI Genomics Co. Ltd. - Key offerings
  • 12.9 Bio Rad Laboratories Inc.
  • Exhibit 139: Bio Rad Laboratories Inc. - Overview
  • Exhibit 140: Bio Rad Laboratories Inc. - Business segments
  • Exhibit 141: Bio Rad Laboratories Inc. - Key news
  • Exhibit 142: Bio Rad Laboratories Inc. - Key offerings
  • Exhibit 143: Bio Rad Laboratories Inc. - Segment focus
  • 12.10 Danaher Corp.
  • Exhibit 144: Danaher Corp. - Overview
  • Exhibit 145: Danaher Corp. - Business segments
  • Exhibit 146: Danaher Corp. - Key news
  • Exhibit 147: Danaher Corp. - Key offerings
  • Exhibit 148: Danaher Corp. - Segment focus
  • 12.11 Eurofins Scientific SE
  • Exhibit 149: Eurofins Scientific SE - Overview
  • Exhibit 150: Eurofins Scientific SE - Business segments
  • Exhibit 151: Eurofins Scientific SE - Key news
  • Exhibit 152: Eurofins Scientific SE - Key offerings
  • Exhibit 153: Eurofins Scientific SE - Segment focus
  • 12.12 F. Hoffmann La Roche Ltd.
  • Exhibit 154: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 155: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 156: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 157: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 158: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.13 Illumina Inc.
  • Exhibit 159: Illumina Inc. - Overview
  • Exhibit 160: Illumina Inc. - Business segments
  • Exhibit 161: Illumina Inc. - Key news
  • Exhibit 162: Illumina Inc. - Key offerings
  • Exhibit 163: Illumina Inc. - Segment focus
  • 12.14 Macrogen Inc.
  • Exhibit 164: Macrogen Inc. - Overview
  • Exhibit 165: Macrogen Inc. - Product / Service
  • Exhibit 166: Macrogen Inc. - Key offerings
  • 12.15 PerkinElmer Inc.
  • Exhibit 167: PerkinElmer Inc. - Overview
  • Exhibit 168: PerkinElmer Inc. - Business segments
  • Exhibit 169: PerkinElmer Inc. - Key news
  • Exhibit 170: PerkinElmer Inc. - Key offerings
  • Exhibit 171: PerkinElmer Inc. - Segment focus
  • 12.16 QIAGEN NV
  • Exhibit 172: QIAGEN NV - Overview
  • Exhibit 173: QIAGEN NV - Product / Service
  • Exhibit 174: QIAGEN NV - Key news
  • Exhibit 175: QIAGEN NV - Key offerings
  • 12.17 Thermo Fisher Scientific Inc.
  • Exhibit 176: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 177: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 178: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 179: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 180: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 181: Inclusions checklist
  • Exhibit 182: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 183: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 184: Research methodology
  • Exhibit 185: Validation techniques employed for market sizing
  • Exhibit 186: Information sources
  • 13.5 List of abbreviations
  • Exhibit 187: List of abbreviations